NRG HN001 Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

June 29, 2018
https://clinicaltrials.gov/ct2/show/NCT02135042
Cancer - Head and Neck
Principal Investigator: Eleanor M Walker, MD
CANCER, NASOPHARYNGEAL, NASOPHARYNGEAL CANCER, STAGE 2, STAGE 3, STAGE 4
Accepting Participants